Skip to main content
. 2021 Oct 29;59(1):1478–1487. doi: 10.1080/13880209.2021.1992448

Table 2.

Antitumour effects of SSD in vivo.

Cancer type Animal models Concn. Administration Duration Suggested mechanism Ref.
Hepatoma HSVtk/Hep3B cells xenograft tumour in nude mice 10 mg/kg Intraperitoneal injection Every other day for 33 days Inhibition of growth. Promotion of apoptosis. Chemosensitization (HSVtk/GCV) (Zhang et al. 2019)
Lung cancer HCC827/GR cells xenograft tumour in nude mice 5, 10 mg/kg Not mentioned Every day for 14 days Inhibition of growth. Promotion of apoptosis. Chemosensitization (gefitinib) (Tang et al. 2019)
Breast cancer MCF-7/ADR cells xenograft tumour in nude mice 5 mg/kg Intraperitoneal injection Every other day for 20 days Inhibition of growth. Inhibition of P-gp expression. Reversal of MDR without toxic effect. (Li, Xue et al. 2017)
Thyroid carcinoma ARO cells xenograft tumour in nude mice 5–20 mg/kg Oral gavage Every day for 4 weeks Inhibition of growth. (Liu and Li 2014)